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Liver allocation was updated on February 4, 2020, replacing a Donor Service Area
(DSA) with acuity circles (AC). The impact on waitlist outcomes for patients listed for
combined liver-intestine transplantation (multivisceral transplantation [MVT]) remains
unknown. The Organ Procurement and Transplantation Network/United Network for
Organ Sharing database was used to identify all candidates listed for both liver and intestine between January 1, 2018 and March 5, 2021. Two eras were defined: pre-AC
(2018–2020) and post-AC (2020–2021). Outcomes included 90-day waitlist mortality
and transplant probability. A total of 127 adult and 104 pediatric MVT listings were
identified. In adults, the 90-day waitlist mortality was not statistically significantly different, but transplant probability was lower post-AC. After risk-adjustment, post-AC
was associated with a higher albeit not statistically significantly different mortality
hazard (sub-distribution hazard ratio[sHR]: 8.45, 95% CI: 0.96–74.05; p = .054), but a
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significantly lower transplant probability (sHR: 0.33, 95% CI: 0.15–0.75; p = .008). For
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eras. The proportion of patients who underwent transplant with exception points was
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pediatric patients, waitlist mortality and transplant probability were similar between
lower post-AC both in adult (44% to 9%; p = .04) and pediatric recipients (65% to
15%; p = .002). A lower transplant probability observed in adults listed for MVT may
ultimately result in increased waitlist mortality. Efforts should be taken to ensure equitable organ allocation in this vulnerable patient population.
KEYWORDS

clinical research/practice, health services and outcomes research, intestine/multivisceral
transplantation, liver transplantation/hepatology, organ allocation, organ procurement and
allocation, organ procurement and transplantation network (OPTN), registry/registry analysis,
united network for organ sharing (UNOS)

Abbreviations: AC, acuity circle; BMI, body mass index; DSA, donor service area; IQR, interquartile range; IRB, institutional review board; LT, liver transplantation; MELD, Model for
End-Stage Liver Disease; MVT, multivisceral transplantation; PELD, Pediatric End-Stage Liver Disease; sHR, sub-distribution hazard ratio; SRTR, Scientific Registry of Transplant
Recipients; STAR, Standard Transplant and Research; STROBE, Strengthening the Reporting of Observational Studies in Epidemiology; UNOS, United Network for Organ Sharing.
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M E TH O D S

The allocation of livers was updated on February 4, 2020, replacing

This study used data from the Organ Procurement and Transplantation

the previous donor service area (DSA)-based allocation model, which

Network (OPTN)/United Network for Organ Sharing (UNOS) registry

was characterized by regional boundaries in the liver and intestinal

from the Standard Transplant and Research (STAR) file, containing

1

organ distribution, with an acuity circle (AC)-based model. The new

information from all patients who were listed for transplantation up

model is based on radially oriented zones around potential donors

until March 5, 2021 in the United States. Patients listed for combined

and involves converting each transplant center's median Model

liver and intestine transplantation, herein referred to as MVT (waitlist

for End-Stage Liver Disease (MELD) score at transplant (MMAT) to

code of WLIN), listed between January 1, 2018 and March 5, 2021,

1

reflect transplants performed within a 250 nautical mile radius.

were identified. Separate analyses were performed for pediatric

Although it aims to increase the number of pediatric transplants and

(<18 years at listing) and adult (≥18 years at listing). A Strengthening

reduce waitlist mortality, concerns have been raised regarding the

the Reporting of Observational Studies in Epidemiology (STROBE)

potential of limiting transplant access for disadvantaged patients. 2

compliant figure of full patient inclusion and exclusion is shown in

Patients listed for combined liver and intestine transplantation,
herein referred to as multivisceral transplantation (MVT), which also

Figure 1A (adults) and Figure 1B (pediatric). This study was approved
for an institutional review board (IRB) waiver after review.

includes the pancreas, represent a particularly vulnerable patient

As AC was introduced on February 4, 2020, two periods were defined

population, who often have undergone multiple prior abdominal op-

according to the date of listing; pre-AC (January 1, 2018 to February 4,

erations, typically have a loss of abdominal domain that mandates spe-

2020) and post-AC February 4, 2020 [inclusive] to March 5, 2021.

cific donor/recipient size matching and have suffered the physiologic
effects of chronic malnutrition.3,4 As these candidates are also undergoing intestine and, frequently, pancreas transplantation in addition

2.1 | Covariates evaluated

to liver transplantation, they also have specific quality requirements
for suitable donors. For this reason, they were previously attributed

Covariates evaluated at listing and at transplant included gender (male

amongst the highest status levels on the liver match run. In the United

or female), age in years (continuous variable), body mass index (BMI)

States, although MVT candidates are registered both on the liver and

(kg/m2), MELD score (continuous), Pediatric End-Stage Liver Disease

intestine waitlists, organ allocation is determined strictly according to

(PELD) (continuous), life support requirement (yes/no), dialysis re-

their ranking in the liver waitlist. They are typically granted MELD ex-

quirement in the week prior to listing and transplant, ascites (yes/no),

ception points because their laboratory scores are often low. Hence,

hepatic encephalopathy (yes/no) (at transplant only), kidney listing

the MELD-Na score alone is not an accurate reflection of their mor-

(which was coded as either WLKP [candidate listed for simultaneous

tality risk. Short gut syndrome with hepatic fibrosis is an appropriate

kidney-pancreas] or WLKI [candidate listed for simultaneous kidney]),

indication for MVT and carries a high mortality risk without transplan-

pancreas listing (which was coded either WLKP or WLPA [candidate

tation, despite a low MELD score in these patients. Transplantation

listed for simultaneous pancreas]), and exception points awarded

represents a life-saving option for such patients and affords an oppor-

(yes/no). Exception points were defined if MELD_DIFF_REASON_CD

5

tunity for improvement in quality of life. In addition to technical and

included code 1 (Not applicable if Candidate is Status 1), 3 (MELD/

physiologic challenges, donor suitability is critical, as the liver, intes-

PELD Exception approved), 8 (Meets Criteria for HCC), 12 (Not appli-

tine, and pancreas all have to be transplantable from the same donor.

cable, Candidate is Status 2A), 14 (Lab Score plus 10% risk of 3-month

Consequently, the available donor pool is considerably smaller, typically

mortality for liver/intestine), 15 (Not applicable, candidate is Status

younger and non-obese donors. This further underscores the need for

1A), 16 (Not applicable, Candidate is Status 1B), 17 (Lab Score plus 23

prioritization when a rare suitably matched donor is identified. This is

points for pediatric liver/intestine), 18 (MELD/PELD exception over-

of particular concern because the current allocation model is routinely

ride). In addition, exception points were assigned as awarded if the

prioritizing these organs to a liver alone candidate that does not have

case was listed as an exception case (EXC_CASE).

the same size and quality limitations and a high “competitive” MELD
score who will likely be allocated another liver promptly. In contrast,
many MVT candidates will need to wait for extended periods for the
next suitable donor to become available. The lack of access for MVT

2.2 | Analysis of waitlist and post-
transplant outcomes

candidates has not been fully addressed by either the MELD-Na-based
allocation system or the new AC policy and has not been included in

The 90-day waitlist outcomes were analyzed using a competing risk

the Scientific Registry of Transplant Recipients (SRTR) models to ana-

analysis with outcomes, including improvement on the waitlist (re-

lyze competing policy proposals. The impact that the AC policy has had

moval code 12), transplantation (removal codes 2–4, 18, 19, 21, and

on patients listed for MVT thus remains to be clarified.

22), or death, including removal for being too sick (removal codes

We sought to evaluate the effect of the AC policy on waitlist

5, 8, and 13). Data were censored if none of the abovementioned

outcomes, specifically regarding waitlist mortality and transplant

events had occurred before the end of the set period. Because dif-

probability, for patients listed for MVT.

ferences in follow-up time can result in withdrawal bias, patients
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F I G U R E 1 (A) Flowchart of patient inclusion and exclusion for adult patients. (B) Flowchart of patient inclusion and exclusion for pediatric patients
registered in each era were censored on the last day of that era

Austria; http://www.R-projec t.org/). Competing risk analysis was

(February 4, 2020 and March 5, 2021, respectively).

performed using the package “cmprsk.”

The 90-day post-transplant patient survival was also compared
between eras. In these comparisons, patients who were listed and
transplanted in the same era were included.

2.3 | Statistical analysis

3

|

R E S U LT S

3.1 | Waitlist patient cohort
3.1.1 | Adult patients

Descriptive data for continuous variables were expressed as and
medians with interquartile range (IQR). These were compared using

A total of 127 adult MVT listings were identified in the study pe-

the Mann–Whitney U test. Categorical variables were expressed as

riod (Figure 1A). Patient characteristics at listing were similar be-

number and percentage and were compared using chi-square and

tween the eras except for a statistically significantly higher Model

Fischer exact test. For comparisons of variables in patients who

for End-stage liver disease (MELD) score at listing in the post-AC

received a transplant, the two groups included patients listed pre-

era group (median [IQR] 12 Pre [8–20] vs. 15 Post [11–23]; p = .04)

AC and transplanted pre-AC and patients listed post-AC and trans-

(Table 1). The proportions of patients listed with exception points

planted post-AC. Patients listed pre-AC but transplanted post-AC

were similar (52% vs. 60%, p = .41). For the patients who received

were thus excluded from the pre-AC group in the abovementioned

exception points and had data available on points requested (wait-

bivariate analysis. For the waitlist analysis, instead of a Kaplan–

list pre-AC 16/36; waitlist post-AC 9/27; transplanted pre-AC 5/17;

Meier approach, which censors for competing events, a cumula-

transplanted post-AC 1/1), the requested points were not statisti-

tive incidence approach was used to account for the presence of

cally significantly different between the two eras (waitlisted patients

competing risks of transplant and waitlist dropout due to mortality.6

median [IQR] 34 [30–36] vs. 32 [30–33]; p = .22; transplanted pa-

A Gray's modified log-rank test was used to compare unadjusted

tients 35 [32–35] vs. 32 [32–32]; p = .77) (Table S1). The proportions

estimates on the waitlist. For assessing the relative change in the

of patients listed for a kidney or a pancreas transplant in addition to

hazard of waitlist dropout due to mortality, a Fine-Gray propor-

MVT were not statistically significantly different between the eras

tional hazards model was used to account for transplant as a com-

(kidney 16% vs. 15%; p = .86; pancreas 100% vs. 100%).

peting event.7 The effect of the exposure of interest (AC era) was
evaluated by multivariable adjustment of confounding variables.
Post-transplant patient survival was compared using the log-rank

3.1.2 | Pediatric patients

test. A p-value <.05 was considered statistically significant for all
analyses. All statistical analyses were performed using R (R version

A total of 104 pediatric MVT listings were identified in the study

4.0.3 [2020–10–10], R foundation for Statistical Computing, Vienna,

period (Figure 1B). Patient characteristics at listing were similar

4
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TA B L E 1 Waitlist characteristics of patients listed for liver-
intestinal transplantation (MVT) stratified by era (adults)

TA B L E 2 Waitlist characteristics of patients listed for liver-
intestinal transplantation (MVT) stratified by era (pediatric)

Pre-AC (N = 74) Post-AC (N = 53) p value
*

Pre-AC
(N = 69)

Post-AC
(N = 35)

p value

Gender, male, n (%)

27 (37%)

21 (40%)

.72

Age at listing, years,
median (IQR)

45 (32, 55)

42 (35, 50)

.89**

Gender, male, n (%)

28 (41%)

15 (43%)

.82*

3 (1, 7)

4 (1, 9)

.53**

BMI at listing, median
(IQR)

23 (21, 27)

.10**

Age at listing, years,
median (IQR)

18 (16, 19)

18 (17, 19)

.90**

MELD score at listing,
median (IQR)

12 (8, 20)

.04**

BMI at listing, median
(IQR)
PELD score at listing,
median (IQR)

7 (0, 17)

3 (−3, 16)

.44**

5 (15%)

.53*

22 (20, 27)
15 (11, 23)

Life support at listing,
n (%)

5 (7%)

N-Missing

0

4

Dialysis requirement in
the week prior to
listing, n (%)

6 (8%)

7 (13%)

Ascites at listing, n (%)

27 (37%)

Exception points
awarded, n (%)

36 (52%)

Listing with kidney, n (%)

12 (16%)

Listing with pancreas,
n (%)

74 (100%)

4 (8%)

.77

*

Life support at listing,
n (%)

14 (20%)

.35*

N-Missing

0

2

2 (3%)

1 (3%)

22 (42%)

.57*

Dialysis requirement
in the week prior
to listing, n (%)

27 (60%)

.41*

N-Missing

1

0

Ascites at listing, n (%)

4 (15%)

0 (0%)

*

.98*

.10**

8 (15%)

.86

N-Missing

43

19

74 (100%)

—

Exception points
awarded, n (%)

40 (63%)

21 (62%)

.94*

Abbreviations: AC, acuity circle; BMI, body mass index (kg/m2); IQR,
interquartile range; MELD, Model for End-Stage Liver Disease.

Listing with kidney,
n (%)

5 (7%)

3 (9%)

.81*

*Kruskal–Wallis rank sum test.; **Pearson's Chi-squared test.

Listing with pancreas,
n (%)

68 (99%)

34 (97%)

.62*

between the eras, including the proportion of patients with excep-

Abbreviations: AC, acuity circle; BMI, body mass index (kg/m2); IQR,
interquartile range; PELD, Pediatric End-Stage Liver Disease.

tion points (63% vs. 62%, p = .94). For the patients who received

*Kruskal–Wallis rank sum test.; **Pearson's Chi-squared test.

exception points and had data available on points requested (waitlist
pre-AC 19/40; waitlist post-AC 4/21; transplanted pre-AC 10/24;
transplanted post-AC 0/2), the requested points were not statisti-

significantly lower 90-day probability of transplant (sHR 0.33, 95%

cally significantly different between the two eras (waitlisted patients

CI 0.15–0.75; p = .008) (Table 3).

median [IQR] 40 [35–60] vs. 35 [35–35]; p = .15; transplanted patients 38 [35–60] vs. 35 [35–35]; p = .38) (Table S2). The proportions
of patients listed for a kidney combined transplant in addition to

3.2.2 | Pediatric patients

MVT were not statistically significantly different between the eras
(kidney 7% vs. 9%; p = .81) (Table 2).

The cumulative incidence of 90-day waitlist mortality (Figure 3A)
and transplant probability (Figure 3B) was not significantly different

3.2 | Waitlist outcomes

between the eras. After multivariable adjustment for PELD score at
listing, receipt of exception points, life support requirement at listing, and dialysis requirement in the week prior to listing, the post-AC

3.2.1 | Adult patients

era was associated with similar 90-day waitlist mortality and transplant probability as the pre-AC era (90-day waitlist mortality sHR

The cumulative incidence of 90-day waitlist mortality was increas-

0.47, 95% CI 0.02–9.76; p = .63; 90-day transplant probability sHR

ing but did not yet reach significance in the post-AC era (p = .08)

1.02, 95% CI 0.47–2.25; p = .95) (Table 4).

(Figure 2A), and transplant probability was significantly lower in the
post-AC era (p = .02) (Figure 2B). After multivariable adjustment for
Model for End-Stage Liver Disease (MELD) score at listing, receipt of

3.3 | Post-transplant outcomes

exception points, life support requirement at listing, and dialysis requirement in the week before listing, the post-AC era was associated

3.3.1 | Adult patients

with increased, albeit not statistically significant, 90-day waitlist
mortality hazard compared to the pre-AC era (sub-distribution haz-

A total of 41 and 11 adult patients were listed and transplanted in

ard ratio [sHR] 8.45, 95% CI 0.96–74.05; p = .054) but a statistically

the pre- and post-AC eras, respectively. Patient characteristics at
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F I G U R E 2 (A) 90-day waitlist mortality stratified by era (adults); (B) 90-day waitlist transplant probability stratified by era (adults)

TA B L E 3 Impact of era (post-AC vs. pre-AC) 90-day waitlist
outcomes (adults)

sHR (95% CI)

hospital (548 miles vs. 334 miles, p = .13) or share type of organs
(national share; 79% vs. 69%, p = .70) was unchanged in the post-

Reference: Pre-AC
Outcomea

post-AC era (65% vs. 15%; p = .002) (Table 6). The distance to donor

AC era. There was no significant difference in laboratory MELD-Na

p-value

score at the time of transplant in patients with or without exception

Mortality

8.45 (0.96–74.05)

.054

points when stratified by era (patients with exception points me-

Transplant

0.33 (0.15–0.75)

.008

dian [IQR] 5 [2–18] vs. 2 [−2–6]; p = .34; patients without exception

Abbreviations: AC, acuity circle; CI, confidence interval; MELD, Model
for End-Stage Liver Disease; sHR, subdistribution hazard ratio.

points 9 [3–12] vs. 20 [10–26]; p = .07) (Table 6). There was no significant difference in the 90-day patient survival rate between the

a

Adjusted for MELD score at listing, life support at listing, exception
points awarded, and dialysis requirement week prior to listing.

eras (p = .09) (Figure 4B).

transplant were similar between the eras, except for a significantly

4

|

DISCUSSION

lower proportion of patients having been awarded exception points
in the post-AC era (44% vs. 9%; p = .04). The distance to donor

Organ allocation in MVT is dictated by the liver transplant waitlist.

hospital (377 miles vs. 335 miles, p = .74) or share type of organs

Similar to liver transplant alone candidates, MVT candidates are

(national share 49% vs. 36%, p = .59) was not changed in the post-

listed and ranked according to their MELD-Na score, which might

AC era (Table 5). There was no significant difference in laboratory

be quite low even in extremely ill patients because they often have

MELD-Na score at the time of transplant in patients with or with-

an absence of advanced liver cirrhosis as the isolated indication for

out exception points when stratified by era (patients with exception

transplant. The current allocation system assigns adult MVT candi-

points patients median [IQR] 21 [15–28] vs. 6 [6–6]; p = .12; patients

dates additional points equivalent to an additional 10% three-month

without exception points 17 [9–28] vs. 25 [17–27]; p = .29) (Table 5).

mortality,8 but that is inadequate to put these patients into the more

There was no significant difference in 90-day post-transplant patient

competitive MELD-Na score categories. This rule of exception points

survival between the pre-and post-AC eras (p = .59) (Figure 4A).

for MVT candidates has remained unchanged in the AC-based allocation policy, but liver allografts are now shared broadly and utilized
as isolated transplants for patients with higher laboratory MELD-Na

3.3.2 | Pediatric patients

scores. This study evaluated the effects of the AC-based allocation
on waitlist outcomes in MVT candidates. It demonstrated that the

There were 38 and 13 pediatric patients who were listed and trans-

transplant probability is significantly lower for adult patients listed

planted in the pre- and post-AC eras. At transplant, a significantly

for MVT after implementing the new AC allocation, and 90-day

lower proportion of patients were awarded exception points in the

waitlist mortality is climbing but has not yet reached significance.

6
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F I G U R E 3 (A) 90-day waitlist mortality stratified by era (pediatric); (B) 90-day waitlist transplant probability stratified by era (pediatric)
TA B L E 4 Impact of era (post-AC vs. pre-AC) 90-day waitlist
outcomes (pediatric)

report, the AC-based allocation significantly increased transplant
probability in liver alone and liver-kidney transplant candidates, and
the positive impact was more clearly observed in the areas where

Reference: Pre-AC

transplant MELD scores were higher (higher MELD regions). While

Outcomea

sHR (95% CI)

p-value

Mortality

0.47 (0.02–9.76)

.63

based allocation on liver transplant candidates in the lower MELD

Transplant

1.02 (0.47–2.25)

.95

score regions, a significant impact on waitlist mortality or transplant

Abbreviations: AC, acuity circle; CI, confidence interval; PELD, Pediatric
End-Stage Liver Disease; sHR, subdistribution hazard ratio.
a

Adjusted for PELD score at listing, life support at listing, exception
points awarded, and dialysis requirement week prior to listing.

there were concerns about the possible negative effects of the AC-

probability has not yet been demonstrated.12 However, this study indicates that we should be concerned that AC-based allocation has
had an adverse effect on waitlist outcomes of MVT candidates. This
population is particularly vulnerable and with extremely high mortality without transplantation. They often have unique medical and sur-

According to the findings of this study, over 60% of MVT candi-

gical issues, including multiple prior surgical procedures frequently

dates were granted MELD exception points. However, this adjust-

with enterocutaneous fistulae, short gut syndrome with resulting

ment may be insufficient to offer these patients access to organs

nutritional challenges, total parenteral nutrition dependence, and line

commensurate with their increased risk. More importantly, although

access issues. Other patients may be listed with a need for liver trans-

the proportions of patients listed with exception points were un-

plantation but with diffuse portomesenteric thrombosis,13 or patients

changed, those who received MVT with exception points were sig-

with otherwise unresectable neuroendocrine tumors.14 These con-

nificantly lower in the post-AC era in adult (44% to 9%) and pediatric

ditions are associated with life-threatening complications, which

(65% to 15%) patients. These results indicate that the exception

may not be well reflected by the MELD-Na score. According to the

points given to those populations would not provide adequate op-

Final Rule, the organs shall be allocated based on medical urgency.

portunities for transplantation. Adult candidates waiting for a liver

However, this may not be a suitable yardstick for patients who are

and intestine experience waitlist mortality twice as high as adult

waiting for MVT. A sole reliance on MELD in MVT patients is not

candidates waiting for a liver only.9,10 Given that MVT patients com-

ideal, as once these patients reach a high physiologic MELD score,

prise less than 1% of all liver transplants performed in the last de-

they may be too sick to transplant and would not tolerate the proce-

cade (632 of 69,694), the impact of ensuring adequate prioritization

dure and recovery. The rules for MVT allocation and exception points

for transplantation is likely to have a negligible effect on liver alone

may require urgent revision to provide meaningful transplant oppor-

candidates.11

tunities to this vulnerable and disadvantaged patient population.

The AC-based allocation was implemented to alleviate the re-

Another critical finding of this study is organ share type and dis-

gional disparity of liver transplant access. According to the recent

tance of donor hospital from the transplant center. The AC-based

IVANICS et al.

TA B L E 5 Transplant characteristics
of patients listed for liver-intestinal
transplantation (MVT) stratified by era
(adults)

AJT
Pre-AC (N = 41)
Distance donor hospital to transplant center,
nautical miles, median (IQR)

377 (147, 646)

p value

335 (187, 714)

.74*
.59**

9 (22%)

2 (18%)

Regional

12 (29%)

5 (46%)

National

20 (49%)

4 (36%)

Gender, male, n (%)

15 (37%)

3 (27%)

.56**

Age at transplant, years, median (IQR)

45 (34, 57)

49 (34, 52)

.81*

BMI at transplant, median (IQR)

25 (22, 31)

26 (24, 29)

.65*

MELD score at transplant, median (IQR)

17 (10, 29)

24 (16, 26)

.76*

MELD score at transplant for patients with
exception points, median (IQR)

21 (15, 28)

6 (6, 6)

.12*

MELD score at transplant for patients without
exception points, median (IQR)

17 (9, 28)

25 (17, 27)

.29*

Life support at transplant, n (%)

5 (12%)

1 (9%)

N-Missing

0

1

.15**

Dialysis requirement in the week prior to listing,
n (%)

10 (24%)

3 (27%)

.85**

Ascites at transplant, n (%)

21 (51%)

6 (55%)

.85**

2 (5%)

1 (9%)

.60**

17 (44%)

1 (9%)

.04**

9 (22%)

0 (0%)

.09**

Hepatic encephalopathy at transplant, n (%)
Exception points awarded, n (%)
Listing with kidney, n (%)
Listing with pancreas, n (%)

41 (100%)

11 (100%)

Total cold ischemic time, hours, median (IQR)

7.0 (6.1, 8.4)

8.0 (6.7–8.7)

.32*

Donor age, years, median (IQR)

25 (21, 30)

29 (22, 33)

.52*

Donor BMI, median (IQR)

22.1 (20.5, 25.1)

7

Post-AC (N = 11)

Organ sharing, n (%)
Local

|

20.2 (19.5, 22.4)

—

.06*

Abbreviations: AC, acuity circle; BMI, body mass index (kg/m2); IQR, interquartile range; MELD,
Model for End-Stage Liver Disease.
*Kruskal–Wallis rank sum test.; **Pearson's Chi-squared test.

F I G U R E 4 (A) 90-day post-transplant patient survival (adults); (B) 90-day post-transplant patient survival (pediatric)
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Distance donor hospital to transplant center,
nautical miles, median (IQR)

Pre-AC (N = 38)

Post-AC (N = 13)

548 (327, 978)

334 (101, 755)

p value
.13*
.70**

Organ sharing, n (%)
Local

3 (8%)

2 (15%)

Regional

5 (13%)

2 (15%)

National

30 (79%)

9 (69%)

Gender, male, n (%)

15 (40%)

5 (39%)

.95**

3 (1, 7)

4 (2, 10)

.51*

18 (17, 20)

19 (18, 19)

.23*

Age at transplant, years, median (IQR)
BMI at transplant, median (IQR)
MELD score at transplant, median (IQR)

8 (2, 14)

15 (9, 25)

.23*

MELD score at transplant for patients with
exception points, median (IQR)

5 (2, 18)

2 (−2, 6)

.34*

MELD score at transplant for patients without
exception points, median (IQR)

9 (3, 12)

20 (10, 26)

.07*

10 (26%)

1 (8%)

.72**

Dialysis requirement in the week prior to
transplant, n (%)

1 (3%)

1 (8%)

.82**

Ascites at transplant, n (%)

4 (18%)

2 (18%)

1.00**

Life support at transplant, n (%)

N-Missing

16

2

Exception points awarded, n (%)

24 (65%)

2 (15%)

.002**

3 (8%)

2 (15%)

.43**

Listing with pancreas, n (%)

37 (97%)

13 (100%)

.56**

Total cold ischemic time, hours, median (IQR)

7.1 (5.9, 8.9)

5.9 (5.0–7.1)

.10*

Listing with kidney, n (%)

Donor age, years, median (IQR)
Donor BMI, median (IQR)

TA B L E 6 Transplant characteristics
of patients listed for liver-intestinal
transplantation (MVT) stratified by era
(pediatric)

1 (0–3)
18.8 (16.0, 21.2)

.69*

1 (0, 3)
16.6 (15.6, 18.6)

.10**

Abbreviations: AC, acuity circle; BMI, body mass index (kg/m2); IQR, interquartile range; MELD,
Model for End-Stage Liver Disease; PELD, Pediatric End-Stage Liver Disease.
*Kruskal-Wallis rank sum test.; **Pearson's Chi-squared test.

allocation has increased broad sharing and increased the distance

100% of adult patients who had the listing code of WLIN (combined

between donor hospitals and transplant centers in the liver trans-

with intestine) were listed for a pancreas graft. Consequently, they

plant alone waitlist.12 MVT grafts have historically been shared

are registered in the liver, pancreas, and intestine waitlists. The cur-

broadly, and transplant teams have been willing to travel nationally

rent OPTN/UNOS policy does not address which waitlist match

even before implementing AC-based allocation. This study revealed

run is used for the second (or third) required organ, resulting in an

that the distance and national share of MVT grafts (sharing organs

inconsistent application of organ allocation policies. Multi-organ

outside of 250 miles radius) were unchanged in adult and pediat-

allocation is often at the discretion of each Organ Procurement

ric MVT. The AC-based allocation accelerated the broad sharing of

Organization (OPO), which sometimes results in the unavailability of

the liver grafts, which might lead to more utilization of non-marginal

pancreas graft, despite liver and intestine grafts being allocated to

liver grafts for liver transplant candidates who have higher MELD-Na

MVT candidates. While the OPTN/UNOS has started discussions,

scores. While this also proved that the AC-based allocation has been

liver-intestine or liver-intestine-pancreas transplant allocation is not

functioning as expected, the broad sharing of the liver graft among

included in this process.15 Because we have already observed that

liver transplant alone patients significantly diminished the opportu-

the AC-based liver allocation adversely impacts MVT waitlist out-

nities for MVT.

comes, multi-organ allocation for this particular population should

Donor suitability is more critical in MVT, which means that mar-

be discussed and clarified without delay.

ginal donors, such as donors with advanced age, donation after cir-

Global differences exist in policies regarding organ allocation

culatory death (DCD), steatotic liver grafts, and donors with a high

for MVT patients. In Europe, patients needing a multi-organ liver

body mass index are often unsuitable for MVT. This has not been

transplant (not including liver-kidney) can be requested to receive

well discussed or recognized in the field. Given the complexity of

an Approved Combined Organ status (ACO).16 This status results in

donor selection in MVT, their priority in liver allocation may need

prioritization above transplantable patients on the liver match but

to be modified. In addition, according to the results of this study,

below patients with a high urgency. Pediatric patients with an ACO

IVANICS et al.
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status are prioritized over adult patients with an ACO status.16 In

D I S C LO S U R E

the United Kingdom, MVT candidates are prioritized ahead of all

The authors of this manuscript have no conflicts of interest to dis-

non-super-urgent liver transplant alone and all kidney and pancreas

close as described by the American Journal of Transplantation.

candidates.17 In Brazil, MVT candidates receive a MELD score of 50,
placing them immediately behind Status 1 candidates. (Information

DATA AVA I L A B I L I T Y S TAT E M E N T

is based on the author's [RV] personal communication.) In Argentina,

The data that support the findings of this study are available

MVT candidates receive an additional 25 MELD points above their

from Organ Procurement and Transplantation Network (OPTN).

laboratory MELD.18 The allocation system in the United States has

Restrictions apply to the availability of these data, which were used

not implemented similar strategies to afford MVT candidates the ap-

under license for this study. Data are available OPTN at https://

propriate prioritization. Moreover, this disadvantage may be further

optn.transplant.hrsa.gov/data/request-data/ with the permission of

aggravated by the AC policy.

OPTN and United Network of Organ Sharing (UNOS).

Limitations of this study should be acknowledged. First, the median MELD at transplant (MMaT) was introduced on May 24th, 2019,

ORCID

before introducing AC-based allocation. The MMaT for liver candi-

Tommy Ivanics

https://orcid.org/0000-0002-1312-4470

dates with exception scores is based on recent LTs performed at liver

Rodrigo Vianna

https://orcid.org/0000-0001-8856-7439

transplant hospitals within the DSA where the candidates are listed.19

Chandrashekhar A. Kubal

Due to the deidentified nature of the data registry, identification of

Kishore R. Iyer

https://orcid.org/0000-0003-4043-2943

https://orcid.org/0000-0002-1446-3271

which center a patient was listed and transplanted in is not possi-

George V. Mazariegos

ble, which precludes an evaluation of differences in exception points

Cal S. Matsumoto

https://orcid.org/0000-0002-2624-8632

https://orcid.org/0000-0002-6364-1927

awarded based on MMaT. Instead, we evaluated requested excep-

Richard Mangus

https://orcid.org/0000-0003-4300-2594

tion points before and after the introduction of MMaT rule, and there

Thiago Beduschi

https://orcid.org/0000-0002-6402-3952

was no difference in exception points. Second, the impact that the

Marwan Abouljoud

https://orcid.org/0000-0002-0044-8281

COVID-19 pandemic has had on allocation practices may represent a

Jonathan A. Fridell

https://orcid.org/0000-0002-8708-1506

source of confounding with potential effects on availability of suitable

Shunji Nagai

https://orcid.org/0000-0003-2612-8427

donors and reduced availability of blood products for major MVT surgery. A recent report of the early effects of AC-based allocation using
the same study period showed that for liver transplant candidates,
the post-AC era has been associated with overall improved waitlist
outcomes with lower 90-day waitlist mortality and a higher transplant probability.12 Though the COVID-19 pandemic may represent
a source of potential confounding, the absence of negative effects
for liver transplant alone candidates lends further credence to the
effects on MVT candidates observed in our study to be more likely
related to the effects of AC-based allocation. Although it is impossible to attribute a causal effect of the AC policy on outcomes in MVT
candidates, given the non-randomized, retrospective design with the
potential for unmeasured and residual confounding even despite the
multivariable analyses performed, this study offers insight into the
outcomes in a limited temporal period before and after a significant
allocation policy change on a population-level transplant scale.
In conclusion, the transplant probability became significantly
lower in patients listed for MVT after implementing the new AC allocation policy. This, in turn, may lead to an increased waitlist mortality for these patients in the long term. These findings highlight that
efforts should be taken to ensure equitable organ allocation in adult
MVT patients and prevent future adverse outcomes.
AC K N OW L E D G M E N T
The data reported here have been supplied by the UNOS as the contractor for the OPTN. The interpretation and reporting of these data
are the responsibility of the author(s) and in no way should be seen
as an official policy of or interpretation by the OPTN or the U.S.
Government.
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